Tenofovir disoproxil fumarate may not cause renal and bone toxicity in chronic hepatitis B patients: a retrospective cross-sectional study

Turk J Med Sci. 2019 Feb 11;49(1):451-452. doi: 10.3906/sag-1805-233.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / adverse effects*
  • Bone Density / drug effects
  • Calcium / blood
  • Cross-Sectional Studies
  • Glomerular Filtration Rate / drug effects
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Hypocalcemia / blood
  • Hypocalcemia / chemically induced
  • Hypophosphatemia / blood
  • Hypophosphatemia / chemically induced
  • Phosphates / blood
  • Retrospective Studies
  • Tenofovir / adverse effects*

Substances

  • Antiviral Agents
  • Phosphates
  • Tenofovir
  • Calcium